Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells |
| |
Authors: | Salma Hazgui Arnaud Bonnomet Béatrice Nawrocki-Raby Magali Milliot Christine Terryn Jér?me Cutrona Myriam Polette Philippe Birembaut Jean-Marie Zahm |
| |
Affiliation: | 1.INSERM, UMRS903, Reims, F-51092 France;2.Univ Reims Champagne Ardenne, IFR53, Reims, F-51100 France;3.CHU Reims, Hôpital Maison Blanche, Laboratoire Pol Bouin, Reims, F-51092 France |
| |
Abstract: | BackgroundMany studies associated the main polyphenolic constituent of green tea, (-)-Epigallocatechin-3-gallate (EGCG), with inhibition of cancers, invasion and metastasis. To date, most of the studies have focused on the effect of EGCG on cell proliferation or death. Since cell migration is an important mechanism involved in tumor invasion, the aim of the present work was to target another approach of the therapeutic effect of EGCG, by investigating its effect on the cell migratory behavior.MethodsThe effect of EGCG (at concentrations lower than 10 μg/ml) on the migration speed of invasive cells was assessed by using 2D and 3D models of cell culture. We also studied the effects of EGCG on proteinases expression by RT-PCR analysis. By immunocytochemistry, we analyzed alterations of vimentin organization in presence of different concentrations of EGCG.ResultsWe observed that EGCG had an inhibitory effect of cell migration in 2D and 3D cell culture models. EGCG also inhibited MMP-2 mRNA and protein expression and altered the intermediate filaments of vimentin.ConclusionTaken together, our results demonstrate that EGCG is able to inhibit the migration of bronchial tumor cells and could therefore be an attractive candidate to treat tumor invasion and cell migration. |
| |
Keywords: | |
|
|